" />

Hemostasis Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Market Outline: Hemostasis Diagnostics Market

Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from the damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.


Market Dynamics: Hemostasis Diagnostics Market

Increase in the incidence of blood clotting disorders such as haemophilia (according to National Hemophilia Foundation, approximately 400,000 incidences of haemophilia is observed in 2012), growing number of trauma patients and surgeries, and the introduction of biodegradable and cost-effective products are expected to propel the hemostasis diagnostics market growth over the forecast period. Moreover, technological advancements in the hemostasis diagnostics such as accurate results in less time, increase in awareness about the hemostasis diagnostics, and rise in R&D investment for novel tests and devices boost the market. However, the high cost of advanced hemostasis products and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market over the forecast period.


A sample of this report is available upon request @



Market Scope: Hemostasis Diagnostics Market

Hemostasis diagnostics market is segmented on the basis of product type, test type, technology, and end user

Based on the product type, the market is segmented into the following:

  • Systems
  • Consumables
  • Point-of-Care Testing Devices


Based on the test type, the market is segmented into the following:

  • Fibrinogen Test
  • Activated Clotting Time
  • Platelet Function
  • Prothrombin Time
  • Heparin & Protamine Dose-Response Test For ACT
  • Activated Partial Thromboplastin Time
  • Anti-Factor Xa
  • Other Coagulation Tests


Based on the technology, the market is segmented into the following:

  • Optical
  • Mechanical
  • Electrochemical
  • Others


Based on the end user, the market is segmented into the following:

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Others (POC)


To view TOC of this report is available upon request @



Market Summary: Hemostasis Diagnostics Market

Hemostasis diagnostics market is growing at a significant rate due to rise in the prevalence of trauma condition and various surgeries around the globe. Moreover, the rise in prevalence of cardiovascular diseases, cancer, and diabetes also expected to propel the market. Furthermore, acquisitions and mergers, collaborations, test approvals, and launchings are the strategies followed by the companies for increasing their revenue share in hemostasis diagnostics market. For instance, in January 2017, Instrumentation Laboratory, a subsidiary of Werfen has acquired Accriva Diagnostics for the expansion of its hemostasis testing portfolio. In addition, in June 2017, Grifols and Beckman Coulter entered into a distribution agreement for the distribution of Grifol’s hemostasis instruments, consumables, and reagents around the globe.


Regional Analysis:  Hemostasis Diagnostics Market

Geographically, hemostasis diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America hemostasis diagnostics market growing at a significant rate due to well-developed healthcare infrastructure, the rise in prevalence of cardiovascular diseases (according to Centers for Disease Control and Prevention, approximately 610,000 deaths are observed due to cardiovascular diseases every year), an increase in awareness about hemostasis diagnostics are anticipated to fuel the market. Europe hemostasis diagnostics market driven by adoption of newer test methods in hemostasis diagnostics, increase in the prevalence of hemostasis condition (according to The European National Registry of Congenital Coagulopathies 2017, the number of cases identified with hemostasis is increased from 7000 in 2000 to 11,000 in 2015), and changes in lifestyle leads to increase in prevalence of CVDs and diabetes, which are expected to propel the market. Asia Pacific hemostasis diagnostics market is growing due to increase in R&D activities in Asia Pacific countries such as Japan, and improving technical capabilities. Latin America hemostasis diagnostics market has a prominent growth due to increase in foreign investment, development in economic growth. Middle East and Africa hemostasis diagnostics market is driven by an increase in the prevalence of hemostasis and other clotting diseases in African countries.


Need more information about this report @



Competition Assessment: Hemostasis Diagnostics Market

Some of the players in the global hemostasis diagnostics market include:

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Sysmex Corporation (Japan)
  • Abbott Laboratories (U.S.)
  • Alere Inc.  (U.S.)
  • Nihon Kohden Corporation (Japan)
  • Siemens Healthineers (Germany)
  • Grifols S.A (Spain)
  • Beckman Coulter, Inc. (U.S.)


Notable Market Developments: Hemostasis Diagnostics Market

  • In November 2016, Siemens Healthineers launched CE-marked Atellica COAG 360 system, a high-volume speciality analyzer used in the hemostasis diagnostics


Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Get access to full summary @



About Precision Business Insights


Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: [email protected]

Posted by on Tuesday April 17 2018, 12:45 PM EST. All trademarks acknowledged. Filed under Biotechnology, Diagnostics, Featured Press Release, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in